OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates

Company Performance - OraSure Technologies reported a quarterly loss of $0.19 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.15, marking an earnings surprise of -26.67% [1] - The company posted revenues of $31.24 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.62%, but down from $54.33 million year-over-year [2] - Over the last four quarters, OraSure has surpassed consensus EPS estimates only once, while it has topped consensus revenue estimates four times [2] Stock Outlook - OraSure shares have declined approximately 13.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $32.71 million, and for the current fiscal year, it is -$0.53 on revenues of $125.84 million [7] Industry Context - The Medical - Products industry, to which OraSure belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact OraSure's stock performance [5]